Internal Medicine, Medical Oncology · Aurora, CO
NPI
1760979744
Since 2018
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
1665 Aurora Ct
Aurora, CO, 80045
Phone (720) 848-0000
Medicare paid, 2024
$32K
329 services
Medicare patients, 2024
76
Average age 71
Drug cost, 2024
$745K
518 prescriptions
Company payments, 2025
$3,542
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alessandra Maleddu was code 99215 (office e&m - established), 110 times for 33 patients. In total Alessandra Maleddu billed 329 services in 13 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 110 | 33 | $109.66 | $12K |
| 99215 Office E&M - Established | Office | 48 | 23 | $130.10 | $6,245 |
| 99214 Office E&M - Established | Office | 44 | 22 | $83.61 | $3,679 |
| 99214 Office E&M - Established | Facility | 43 | 12 | $74.07 | $3,185 |
| 99213 Office E&M - Established | Office | 19 | 12 | $51.22 | $973 |
| 99205 Office E&M - New | Facility | 18 | 18 | $130.97 | $2,358 |
By year: 2022 $4,646 for 58 services; 2023 $17K for 200 services; 2024 $32K for 329 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alessandra Maleddu prescribed most often to Medicare patients was Imatinib Mesylate, with 35 prescriptions and refills. In total Alessandra Maleddu wrote 518 Medicare prescriptions that cost $745K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 35 | 35 | Under 11 | $4,787 |
| Oxycodone Hcl Generic | 33 | 35 | 12 | $659 |
| Ondansetron Hcl Generic | 30 | 32 | 17 | $337 |
| Koselugo Selumetinib Sulfate | 23 | 23 | Under 11 | $292K |
| Prochlorperazine Maleate Generic | 22 | 22 | 15 | $313 |
| Potassium Chloride Generic | 18 | 24 | Under 11 | $195 |
| Gabapentin Generic | 17 | 27 | Under 11 | $480 |
| Lorazepam Generic | 15 | 15 | Under 11 | $35.91 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 14 | 14 | Under 11 | $159 |
| Prednisone Generic | 14 | 14 | Under 11 | $23.99 |
| Alprazolam Generic | 13 | 13 | Under 11 | $35.65 |
| Dexamethasone Generic | 13 | 13 | Under 11 | $87.81 |
| Creon Lipase/Protease/Amylase | 13 | 13 | Under 11 | $23K |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 12 | 16 | Under 11 | $40.35 |
| Eliquis Apixaban | 12 | 16 | Under 11 | $10K |
Brand drugs: - claims; generic drugs: 427 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alessandra Maleddu $3,542 ($3,542 in general payments such as food, travel and fees) from 4 companies. The largest payer was SpringWorks Therapeutics, Inc. with $3,000.
| Company | Payments | Amount |
|---|---|---|
| SpringWorks Therapeutics, Inc. | 1 | $3,000 |
| Daiichi Sankyo Inc. 4568.T | 1 | $542 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.